ArticleBioinformatics advances2025
PSO-FeatureFusion: a general framework for fusing heterogeneous features via particle swarm optimization.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- RLASON-CDR: a reinforcement learning-driven adaptive synergistic optimization network for cancer drug response prediction.Briefings in bioinformatics · 2026Article
- DualKG-DC: A Drug-Centric Dual-Layer Knowledge Graph Framework for Drug Combination Prediction.Journal of medical systems · 2026Article
- PDTSyn: a parameter-decomposed transformer for domain-generalized cell line-aware drug synergy prediction.Briefings in bioinformatics · 2026Article
- Advancing Drug-Drug Interaction Prediction with Biomimetic Improvements: Leveraging the Latest Artificial Intelligence Techniques to Guide Researchers in the Field.Biomimetics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Integrating heterogeneous biological data is a central challenge in bioinformatics, especially when modeling complex relationships among entities such as drugs, diseases, and molecular features. Existing methods often rely on static or separate feature extraction processes, which may fail to capture interactions across diverse feature types and reduce predictive accuracy. Results: To address these limitations, we propose PSO-FeatureFusion, a unified framework that combines particle swarm optimization with neural networks to jointly integrate and optimize features from multiple biological entities. By modeling pairwise feature interactions and learning their optimal contributions, the framework captures individual feature signals and their interdependencies in a task-agnostic and modular manner. We applied PSO-FeatureFusion to two bioinformatics tasks-drug-drug interaction and drug-disease association prediction-using multiple benchmark datasets. Across both tasks, the framework achieved strong performance across evaluation metrics, often outperforming or matching state-of-the-art baselines, including deep learning and graph-based models. The method also demonstrated robustness with limited hyperparameter tuning and flexibility across datasets with varying feature structures. PSO-FeatureFusion provides a scalable and practical solution for researchers working with high-dimensional biological data. Its adaptability and interpretability make it well-suited for applications in drug discovery, disease prediction, and other bioinformatics domains. Availability and implementation: The source code and datasets are available at https://github.com/raziyehmasumshah/PSO-FeatureFusion.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.